Ledger.Open graph →

SEC Form D · filed August 24, 2022

BioSplice Therapeutics, Inc

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Osman Kibar · San Diego, CADirector Susannah Gray · San Diego, CADirector Karen Mcginnis · San Diego, CADirector Gur Roshwalb · San Diego, CADirector Kyle Rasbach · San Diego, CADirector Jeremy Wilson · Rogers, ARDirector NewRoad Fund IV GP, L.P · Rogers, ARDirector Brendan W. Lake · Conshohocken, PADirector Christopher T. Ladd · Rogers, ARDirector Yusuf Yazici · San Diego, CAExec Scott Bulcao · San Diego, CAExec Darrin Beaupre · San Diego, CAExec Troy Cox · South San Franciscoc, CADirector Erich Horsley · Cambridge, MAExec Cevdet Samikoglu · Purchase, NYExec · Director Walter W. Buckley Iii · Chester Springs, PADirector Kirby Winfield · Seattle, WADirector Joanna L. Lohkamp · Los Angeles, CADirector Sandi S. Bragar · Los Angeles, CADirector Yusuf Yazici · San Diego, CAExec Scott Bulcao · San Diego, CAExec Darrin Beaupre · San Diego, CAExec Troy Cox · San Diego, CADirector Erich Horsley · Cambridge, MAExec Cevdet Samikoglu · San Diego, CAExec · Director Kyle Rasbach · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗